HAART

Antiretroviral Therapy for Acute and Chronic HIV Infection

ARVs to Prevent Breastmilk HIV:Viral and Immune Responses

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects

Valproic Acid and Its Effects on HIV Latent Reservoirs

CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients

Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda

Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

HIV - Monotherapy in Switzerland (MOST-ch)

Children With HIV and Asthma (CHIVAS)

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).

Single DermaVir Immunization in HIV-1 Infected Patients on HAART

Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx

Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients

Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients

Intermittent Versus Continuous Medication in the Treatment of HIV

Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children